Current Clinical Trials

Phase 3 Study

Moderate-to-Severe Alcohol Use Disorder

RENEW-ALC-1

Mountain Mind Co. is participating in a Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared with Placebo for the Treatment of Adult Participants with Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1). We are currently seeking eligible adult participants.

If you feel you may qualify for this study and would like to be considered for participation, please click the link below for a no cost phone consultation.

Phase 3 Study

Major Depressive Disorder

Phase 3 Open-Label Safety Study of Bretisilocin for the Acute Treatment of Major Depressive Disorder.

If you feel you may qualify for this study and would like to be considered for participation, please click the link below for a no cost phone consultation.